CompletedPhase 4NCT00669643
Uniform Multidrug Therapy Regimen for Leprosy Patients
Studying Leprosy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Brasilia
- Principal Investigator
- Gerson O Penna, MD, PhDUniversity of Brasilia
- Intervention
- PB 6 doses - Rifampicin and Dapsone(drug)
- Enrollment
- 859 enrolled
- Eligibility
- 6-65 years · All sexes
- Timeline
- 2007 – 2016
Study locations (2)
- Centro de Referência Nacional Alfredo da Matta - FUAM, Manaus, Amazonas, Brazil
- Centro de Referência Nacional Dona Libânia - CDERM, Fortaleza, Ceará, Brazil
Collaborators
Conselho Nacional de Desenvolvimento Científico e Tecnológico · Ministry of Science and Technology, Brazil · Ministry of Health, Brazil · Fundação Alfredo da Matta, Manaus, Brazil · Instituto de Dermatologia Dona Libania, Fortaleza, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00669643 on ClinicalTrials.govOther trials for Leprosy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06761469Leprosy Active Searching Trial in BrazilHospital Alemão Oswaldo Cruz
- RECRUITINGNANCT06819449Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy PatientsSouth Valley University
- RECRUITINGNCT06683690TGF β 1 Expression Related Gene PolymorphismAswan University
- RECRUITINGPHASE3NCT05597280Bedaquiline Enhanced Post ExpOsure Prophylaxis for LeprosyInstitute of Tropical Medicine, Belgium
- RECRUITINGPHASE2NCT05243654Efficacy and Tolerability of Adjunct Metformin for Multibacillary LeprosyOxford University Clinical Research Unit Indonesia
- RECRUITINGNANCT06222372Novel Interventions and Diagnostic Tests for LeprosyAnnemieke Geluk